Topics
Glioblastoma | Treatment | Immunotherapy | MGMT expression
Home > Publications > Topics > Glioblastoma > Treatment > Immunotherapy > MGMT expression
Kushihara Y, Tanaka S, Kobayashi Y,
Nagaoka K, Kikuchi M, Nejo T, Yamazawa E, Nambu S, Kugasawa K,
Takami H, Takayanagi S, Saito N, Kakimi K.
Glioblastoma
with high O6-methyl-guanine DNA methyltransferase expression are
more immunologically active than tumors with low MGMT
expression.
Front
Immunol. 2024 Jan
15;15:1328375. doi:
10.3389/fimmu.2024.1328375. PMID:
38288307. Laboratory investigation, Observational study. ˍ